Results 71 to 80 of about 305 (130)

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease

Life
Background: Gaucher disease (GD) is a lysosomal storage disorder caused by deficiency of β-glucocerebrosidase, leading to accumulation of glucocerebroside in lysosomes.
Patryk Lipiński, Dariusz Rokicki, Karolina Chwiałkowska, Michał Ciborowski, Joanna Godzień, Aleksandra Jezela-Stanek, Urszula Korotko, Mirosław Kwaśniewski, Magdalena Niemira, Paulina Szymańska-Rożek, Małgorzata Syczewska, Anna Tylki-Szymańska   +11 more
doaj   +1 more source

Evaluation of the Role of Postnatal Ambroxol in the Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates

Sultan Qaboos University Medical Journal, 2006
Objective: to study the effect of the postnatal administration of Ambroxol in the prevention of respiratory distress syndrome in preterm neonates at risk and on the severity of the disease in those neonates already suffering from it.
Hesham F Elsayed, Muhammed I Elkhaiouby, Sunia M Elsharkawey, Muna A Elnemr   +3 more
doaj  

Impact of mycolytic therapy on the production of active oxygen formS in the blood of patients with an exacerbation of chronic obstructive pulmonary disease

Терапевтический архив, 2010
Aim. To study the production of active oxygen forms (AOF) in the blood of patients with an exacerbation of chronic obstructive pulmonary disease (COPD) and the effect of the mycolytic agent Ambroxol on this process. Subjects and methods.
Usman Raul'evich Farkhutdinov, Rafagat Ravil'evich Farkhutdinov, Valeriy Vladislavovich Petryakov, Shamil' Usmanovich Farkhutdinov, Al'bert Marsel'evich Mirkhaydarov, U R Farkhutdinov, R R Farkhutdinov, V V Petryakov, Sh U Farkhutdinov, A M Mirkhaidarov   +9 more
doaj  

Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways

Frontiers in Aging Neuroscience
Alzheimer’s disease (AD) is the most common and costly chronic progressive neurodegenerative disorder, with the highest impact on public health worldwide.
Waqas Ahmad, Kyonghwan Choe, Kyonghwan Choe, Riaz Ahmad, Tae Ju Park, Myeong Ok Kim, Myeong Ok Kim   +6 more
doaj   +1 more source

The efficacy of nebulized budesonide and ambroxol hydrochloride in treating pediatric community-acquired pneumonia and their impact on clinical characteristics and inflammatory markers

Journal of Health, Population and Nutrition
Purpose To evaluate the therapeutic efficacy of intravenous amoxicillin clavulanate potassium combined with nebulized budesonide and ambroxol hydrochloride in pediatric community-acquired pneumonia (CAP) and its impact across various microbial strains ...
Xiaoqin Zhang, Xiaohua Zhang, Jinhua Gu, Lin Zhang, Rong Yang   +4 more
doaj   +1 more source

Clinical efficacy and safety of high-dose ambroxol in the form of oromucosal spray in postnasal drip syndrome: results of a multicenter study in Ukraine

Medičnì Perspektivi
Postnasal drip syndrome (PNDS) is one of the most common clinical conditions in the practice of otolaryngologists and family physicians, characterized by the drainage of mucous or mucopurulent secretions along the posterior wall of the pharynx and ...
Yu.V. Deeva , et al. co-authors
doaj   +1 more source

Ambroxol for the treatment of fibromyalgia: science or fiction?

Journal of Pain Research, 2017
Kai-Uwe Kern, Myriam Schwickert Institute of Pain Medicine/Pain Practice, Wiesbaden, Germany Abstract: Fibromyalgia appears to present in subgroups with regard to biological pain induction, with primarily inflammatory, neuropathic/neurodegenerative ...
Kern KU, Schwickert M
doaj  

Clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of senile severe pneumonia

Guoji laonian yixue zazhi
[Objective] To investigate the clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of elderly patients with severe pneumonia.
Lu Qiuying, Gao Yanfen, Shan Yan, Xu Yaping   +3 more
doaj   +1 more source

Efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infection in children: a multicenter, randomized, double-blind, placebo-controlled trial

BMC Pulmonary Medicine
Objective To evaluate the efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infections (LRTIs) in children.
Baoping Xu, Peng Han, Yunxiao Shang, Huanji Cheng, Zhiying Han, Lin Zhao, Shaoru He, Min Lu, Enmei Liu, Kunling Shen   +9 more
doaj   +1 more source